当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 资产负债表

科伦药业

(002422)

  

流通市值:382.80亿  总市值:469.11亿
流通股本:13.07亿   总股本:16.02亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金6,141,215,4904,445,988,3185,939,843,7754,728,905,239
应收票据及应收账款4,966,313,5675,529,093,3355,754,655,5925,696,458,999
应收账款4,966,313,5675,529,093,3355,754,655,5925,696,458,999
应收款项融资1,210,737,8501,249,055,7911,659,404,7051,501,367,165
预付款项714,420,448459,802,790572,566,494429,817,506
其他应收款合计212,359,117205,589,695267,781,799256,304,108
其中:应收利息16,601,1276,829,9225,274,5505,215,978
应收股利---7,222,169
存货3,080,310,0033,131,214,2863,146,557,6733,214,089,699
其他流动资产546,386,558414,535,244422,271,279372,680,191
流动资产平衡项目0000
流动资产合计17,673,464,21416,919,576,77918,385,080,64216,647,731,231
非流动资产:
长期股权投资4,011,918,8073,976,785,7613,838,331,5453,793,778,616
其他权益工具投资15,014,15115,014,15115,014,15116,733,451
固定资产9,511,703,0139,685,009,0959,915,172,26510,132,221,665
在建工程1,881,674,4661,479,415,2411,225,973,9701,125,777,819
使用权资产272,460,471271,772,560265,812,48073,295,336
无形资产1,226,388,8581,231,613,9141,224,901,6381,201,433,224
开发支出90,855,893118,650,223145,184,790157,771,466
商誉98,659,99498,659,99498,659,99498,659,994
长期待摊费用62,643,33061,270,33664,611,09076,037,761
递延所得税资产690,833,972686,449,270625,897,057618,069,648
其他非流动资产424,303,146358,823,775300,864,883264,338,722
非流动资产平衡项目0000
非流动资产合计18,286,456,10117,983,464,32017,720,423,86317,558,117,702
资产平衡项目0000
资产总计35,959,920,31534,903,041,09936,105,504,50534,205,848,933
流动负债:
短期借款3,210,137,0693,311,635,5553,762,849,5703,290,694,668
交易性金融负债665,8944,242,3631,084,237-
应付票据及应付账款2,246,528,9312,233,181,0392,052,076,7332,244,333,847
其中:应付票据163,572,997205,219,915139,309,604237,777,226
应付账款2,082,955,9342,027,961,1241,912,767,1292,006,556,621
合同负债831,148,487964,146,1431,008,778,359360,362,679
应付职工薪酬227,627,784201,882,247167,288,811253,866,836
应交税费232,527,894218,715,463245,518,110274,566,935
其他应付款合计1,842,301,4373,835,576,4163,855,293,4612,419,062,102
应付股利1,416,2251,470,834--
一年内到期的非流动负债917,700,6161,006,863,6081,089,488,2312,029,524,527
其他流动负债28,683,178447,769,189830,929,2301,231,701,670
流动负债平衡项目0000
流动负债合计9,537,321,29012,224,012,02313,013,306,74212,104,113,264
非流动负债:
长期借款1,504,803,3331,504,803,3331,840,479,9962,035,500,000
应付债券1,915,936,8001,899,054,6411,938,318,5552,668,887,650
租赁负债232,155,264235,691,732249,387,63551,738,205
预计负债5,327,9343,414,9782,512,542-
递延收益238,981,397217,619,619202,196,840208,884,466
递延所得税负债318,208,515326,008,437263,868,716265,730,659
非流动负债平衡项目0000
非流动负债合计4,215,413,2434,186,592,7404,496,764,2845,230,740,980
负债平衡项目0000
负债合计13,752,734,53316,410,604,76317,510,071,02617,334,854,244
所有者权益(或股东权益):
实收资本(或股本)1,475,051,7691,475,047,2351,471,269,7801,422,247,156
其他权益工具210,057,771210,065,289216,339,515300,630,962
资本公积5,703,177,8523,831,801,6553,713,249,4243,672,964,859
减:库存股215,380,510215,380,510237,075,644237,075,644
其他综合收益229,952,815243,891,616110,988,761159,193,032
盈余公积1,230,157,4291,230,157,4291,230,157,4291,230,157,429
未分配利润10,249,704,9139,710,812,16810,018,755,8369,186,146,699
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计18,882,722,03916,486,394,88216,523,685,10115,734,264,493
少数股东权益3,324,463,7432,006,041,4542,071,748,3781,136,730,196
股东权益平衡项目0000
股东权益合计22,207,185,78218,492,436,33618,595,433,47916,870,994,689
负债和股东权益合计35,959,920,31534,903,041,09936,105,504,50534,205,848,933
公告日期2023-10-312023-08-302023-04-262023-04-14
审计意见(境内)标准无保留意见
TOP↑